The Deal
Sunday, November 8, 
7:45 pm

Royal Dutch Shell ups ethanol stakes in Iogen Energy

  Share     E-Mail    Discussion    Print Story

Canadian biofuel developer Iogen Energy Corp. took on an undisclosed but potentially huge amount of additional investment from Royal Dutch Shell plc, which is boosting its stake in the cellulosic ethanol producer from 26.3% to 50%. Shell first invested in Iogen in 2002 and holds its position alongside other venture and strategic investors Goldman, Sachs & Co. [GS], Petro-Canada, the government of Canada and biotech producer Royal DSM NV.

Shell, along with Chevron Corp. [CVX], and BP plc (which even boasts Beyond Petroleum as a marketing slogan), has been an active investor in all kinds of alternative fuel development, in marked contrast with Exxon Corp. [XOM], which has fought with investors over its intransigence about alternative fuel and global warming initiatives. But the Iogen commitment is particularly significant in making such a big play in liquid fuels that directly compete with gasoline.
  
Shell's investment will support additional technology development as part of the oil giant's commitment to next-generation biofuels that use non-food feedstocks, advancing Iogen's work with raw materials such as wheat straw. Iogen opened a demonstration plant in Ottawa in 2004, and the Shell investment may support a full-scale commercial plant currently in feasibility and design assessment studies.

In addition to ethanol production, Iogen is working on broad biotechnology applications that include development and manufacturing of enzymes in textile, animal feed and pulp and paper industries. The investment from DMS (formerly Roche Vitamins) is related to work the company is doing with enzymes used in animal feed, while the Canadian government has invested partly to support work that is being done in enzyme development with the country's large pulp and paper industry. -- Clifford Carlsen

See July 15 press release from Iogen Energy
See May 27 post from Corporate Dealmaker
For more see Green Car Congress

Continue reading below

Also on Dealscape





Post a comment




The Deal Pipeline

Deal Video


Inside The Deal: Linklaters' Schmidt says how regulators handled Pfizer Inc.'s acquisition of Wyeth is an outlier of how others merger reviews will be conducted.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Dealing with frozen bank lending

If your bank is not willing to lend, what can you do as your company continues to seek growth?


Judgment Call

The coming age of the renminbi

The Chinese currency will play an increasingly important role in international commerce and finance.


Industry Insight

Banking on PE investments

Howls of protest greeted the FDIC policy statement, but the financial services industry should get over it.



©Copyright 2008, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.